DURECT Corp (DRRX), Pain Therapeutics (PTIE) Remoxy ER doesn't qualify for FD&C Act exemption - FDA

September 14, 2016 10:25 AM EDT
Get Alerts PTIE Hot Sheet
Trade PTIE Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

FDA says DURECT Corp (NASDAQ: DRRX) and Pain Therapeutics (NASDAQ: PTIE) Remoxy ER doesn't qualify for FD&C Act exemption.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk

Add Your Comment